NS2B AS MARKER FOR ZIKA VIRUS INFECTIONS

NS2B AS MARKER FOR ZIKA VIRUS INFECTIONS

The present invention relates to protein NS2b or fragment(s) thereof as biomarker or diagnostic marker for the diagnosis and/or prognosis of Zika virus infections. The present invention further relates to peptides and cyclic peptides, compositions and arrays and multimer compounds comprising them. T...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SEKUL, RENATE, MARQUES, ERNESTO T. A, JAENISCH, THOMAS, FISCHER, NICO, LOEFFLER, FELIX, STADLER, VOLKER
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
TESTING
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SEKUL, RENATE
MARQUES, ERNESTO T. A
JAENISCH, THOMAS
FISCHER, NICO
LOEFFLER, FELIX
STADLER, VOLKER
description The present invention relates to protein NS2b or fragment(s) thereof as biomarker or diagnostic marker for the diagnosis and/or prognosis of Zika virus infections. The present invention further relates to peptides and cyclic peptides, compositions and arrays and multimer compounds comprising them. The present invention further relates to a method for the diagnosis and/or prognosis of Zika virus infections, comprising the use of protein NS2b or fragment(s) thereof, or of the peptides, cyclic peptides, compositions and/or arrays in immunoassays. The present invention further relates to peptide-based compounds comprising at least one fragment of protein NS2b and at least one further component and to methods for the diagnosis and/or prognosis of Zika virus infections.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2020325183A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2020325183A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2020325183A13</originalsourceid><addsrcrecordid>eNrjZNDwCzZyUnAMVvB1DPJ2DVJw8w9SiPL0dlQI8wwKDVbw9HNzdQ7x9PcL5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgZGBsZGpoYWxo6GxsSpAgB47yTD</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NS2B AS MARKER FOR ZIKA VIRUS INFECTIONS</title><source>esp@cenet</source><creator>SEKUL, RENATE ; MARQUES, ERNESTO T. A ; JAENISCH, THOMAS ; FISCHER, NICO ; LOEFFLER, FELIX ; STADLER, VOLKER</creator><creatorcontrib>SEKUL, RENATE ; MARQUES, ERNESTO T. A ; JAENISCH, THOMAS ; FISCHER, NICO ; LOEFFLER, FELIX ; STADLER, VOLKER</creatorcontrib><description>The present invention relates to protein NS2b or fragment(s) thereof as biomarker or diagnostic marker for the diagnosis and/or prognosis of Zika virus infections. The present invention further relates to peptides and cyclic peptides, compositions and arrays and multimer compounds comprising them. The present invention further relates to a method for the diagnosis and/or prognosis of Zika virus infections, comprising the use of protein NS2b or fragment(s) thereof, or of the peptides, cyclic peptides, compositions and/or arrays in immunoassays. The present invention further relates to peptide-based compounds comprising at least one fragment of protein NS2b and at least one further component and to methods for the diagnosis and/or prognosis of Zika virus infections.</description><language>eng</language><subject>CHEMISTRY ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; TESTING</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20201015&amp;DB=EPODOC&amp;CC=US&amp;NR=2020325183A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20201015&amp;DB=EPODOC&amp;CC=US&amp;NR=2020325183A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SEKUL, RENATE</creatorcontrib><creatorcontrib>MARQUES, ERNESTO T. A</creatorcontrib><creatorcontrib>JAENISCH, THOMAS</creatorcontrib><creatorcontrib>FISCHER, NICO</creatorcontrib><creatorcontrib>LOEFFLER, FELIX</creatorcontrib><creatorcontrib>STADLER, VOLKER</creatorcontrib><title>NS2B AS MARKER FOR ZIKA VIRUS INFECTIONS</title><description>The present invention relates to protein NS2b or fragment(s) thereof as biomarker or diagnostic marker for the diagnosis and/or prognosis of Zika virus infections. The present invention further relates to peptides and cyclic peptides, compositions and arrays and multimer compounds comprising them. The present invention further relates to a method for the diagnosis and/or prognosis of Zika virus infections, comprising the use of protein NS2b or fragment(s) thereof, or of the peptides, cyclic peptides, compositions and/or arrays in immunoassays. The present invention further relates to peptide-based compounds comprising at least one fragment of protein NS2b and at least one further component and to methods for the diagnosis and/or prognosis of Zika virus infections.</description><subject>CHEMISTRY</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDwCzZyUnAMVvB1DPJ2DVJw8w9SiPL0dlQI8wwKDVbw9HNzdQ7x9PcL5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgZGBsZGpoYWxo6GxsSpAgB47yTD</recordid><startdate>20201015</startdate><enddate>20201015</enddate><creator>SEKUL, RENATE</creator><creator>MARQUES, ERNESTO T. A</creator><creator>JAENISCH, THOMAS</creator><creator>FISCHER, NICO</creator><creator>LOEFFLER, FELIX</creator><creator>STADLER, VOLKER</creator><scope>EVB</scope></search><sort><creationdate>20201015</creationdate><title>NS2B AS MARKER FOR ZIKA VIRUS INFECTIONS</title><author>SEKUL, RENATE ; MARQUES, ERNESTO T. A ; JAENISCH, THOMAS ; FISCHER, NICO ; LOEFFLER, FELIX ; STADLER, VOLKER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2020325183A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2020</creationdate><topic>CHEMISTRY</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>SEKUL, RENATE</creatorcontrib><creatorcontrib>MARQUES, ERNESTO T. A</creatorcontrib><creatorcontrib>JAENISCH, THOMAS</creatorcontrib><creatorcontrib>FISCHER, NICO</creatorcontrib><creatorcontrib>LOEFFLER, FELIX</creatorcontrib><creatorcontrib>STADLER, VOLKER</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SEKUL, RENATE</au><au>MARQUES, ERNESTO T. A</au><au>JAENISCH, THOMAS</au><au>FISCHER, NICO</au><au>LOEFFLER, FELIX</au><au>STADLER, VOLKER</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NS2B AS MARKER FOR ZIKA VIRUS INFECTIONS</title><date>2020-10-15</date><risdate>2020</risdate><abstract>The present invention relates to protein NS2b or fragment(s) thereof as biomarker or diagnostic marker for the diagnosis and/or prognosis of Zika virus infections. The present invention further relates to peptides and cyclic peptides, compositions and arrays and multimer compounds comprising them. The present invention further relates to a method for the diagnosis and/or prognosis of Zika virus infections, comprising the use of protein NS2b or fragment(s) thereof, or of the peptides, cyclic peptides, compositions and/or arrays in immunoassays. The present invention further relates to peptide-based compounds comprising at least one fragment of protein NS2b and at least one further component and to methods for the diagnosis and/or prognosis of Zika virus infections.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2020325183A1
source esp@cenet
subjects CHEMISTRY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
TESTING
title NS2B AS MARKER FOR ZIKA VIRUS INFECTIONS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T17%3A40%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SEKUL,%20RENATE&rft.date=2020-10-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2020325183A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true